Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TE-8105 by Immunwork for Obesity: Likelihood of Approval
TE-8105 is under clinical development by Immunwork and currently in Phase I for Obesity. According to GlobalData, Phase I drugs...